A recombinant uricase for treatment of chronic gout refractory to conventional therapy

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2010年 / 45卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [1] Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
    Baraf, Herbert S. B.
    Yood, Robert A.
    Ottery, Faith D.
    Sundy, John S.
    Becker, Michael A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (08) : 427 - 432
  • [2] Learning how and when to employ uricase as bridge therapy in refractory gout
    Terkeltaub, Robert
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (10) : 1955 - 1958
  • [3] A PEGylated Mammalian Uricase Suitable for Intramuscular Administration to Patients with Refractory Chronic Gout
    Fan, Frank
    Liu, Riyong
    Wang, Yu
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4108 - 4110
  • [4] Long-term safety of pegloticase in chronic gout refractory to conventional treatment
    Becker, Michael A.
    Baraf, Herbert S. B.
    Yood, Robert A.
    Dillon, Aileen
    Vazquez-Mellado, Janitzia
    Ottery, Faith D.
    Khanna, Dinesh
    Sundy, John S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (09) : 1469 - 1474
  • [5] PegloticaseIn Treatment-Refractory Chronic Gout
    Katherine A. Lyseng-Williamson
    Drugs, 2011, 71 : 2179 - 2192
  • [6] Pegloticase In Treatment-Refractory Chronic Gout
    Lyseng-Williamson, Katherine A.
    DRUGS, 2011, 71 (16) : 2179 - 2192
  • [7] Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment Two Randomized Controlled Trials
    Sundy, John S.
    Baraf, Herbert S. B.
    Yood, Robert A.
    Edwards, N. Lawrence
    Gutierrez-Urena, Sergio R.
    Treadwell, Edward L.
    Vazquez-Mellado, Janitzia
    White, William B.
    Lipsky, Peter E.
    Horowitz, Zeb
    Huang, William
    Maroli, Allan N.
    Waltrip, Royce W., II
    Hamburger, Steven A.
    Becker, Michael A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (07): : 711 - 720
  • [8] Omalizumab treatment in a patient with conventional therapy refractory to autoimmune chronic urticaria
    Maghfour Martin, Y.
    Dominguez Dominguez, E.
    Gomez Nieves, E.
    Porcel Carreno, S.
    Ahmida, T.
    Hernandez Arbeiza, J.
    Alvarado Arenas, M.
    Jimenez Timon, S.
    ALLERGY, 2012, 67 : 356 - 356
  • [9] Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy
    Zhang, Ziang
    Fu, Nannan
    Li, Qinkai
    Quan, Junmin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 666 : 115 - 121
  • [10] Resolution of tophi with intravenous peg-uricase in refractory gout.
    Baraf, HSB
    Kim, S
    Matsumoto, AK
    Maroli, AN
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S105 - S105
12345